CLIMB BIO INC. - COMMON STOCK

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

27 6 2024 15:01:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

11 4 2024 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

20 7 2023 05:45:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

11 5 2023 15:10:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights

06 3 2023 15:10:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition

09 2 2023 15:01:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

30 11 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

14 11 2022 05:10:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

08 11 2022 06:00:02 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Provides Update on Pipeline Progress

05 10 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Reports Second Quarter Financial and Business Highlights

15 8 2022 05:10:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Provides ETX-810 Program Update

02 8 2022 06:00:01 提供 Nasdaq GlobeNewswire

Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder

18 7 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

07 7 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)

27 6 2022 15:01:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Reports First Quarter Financial and Business Highlights

16 5 2022 05:10:00 提供 Nasdaq GlobeNewswire

Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs

25 4 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs

05 4 2022 06:00:01 提供 Nasdaq GlobeNewswire

Eliem Therapeutics to Present at Stifel’s 2022 CNS Days

21 3 2022 06:00:00 提供 Nasdaq GlobeNewswire

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights

07 3 2022 15:10:00 提供 Nasdaq GlobeNewswire